PDP Holdings is a company that works with surgeons, hospitals and device manufacturers to provide high quality implants at a lower cost. Their business model allows surgeons to select implants — oftentimes from the same suppliers they already use in the operating room — and purchase them directly from the manufacturer, cutting out the distributor and sales rep as the "middle men" in the equation.
Here are three benefits of a PDP's direct purchase implant model:
1. Hospital benefits. Joseph Truhe, senior vice president and general counsel for PDP Holdings, says hospitals can save 10 to 20 percent or more, on these surgical devices, even for the identical supplier. In one case, the company was able to save a Texas hospital 40 percent on devices on a DRG comparison, accounting for the elimination of "upselling" in the OR and the use of non-premium equivalents. Such savings are particularly attractive if the hospital is participating in accountable care organizations, bundled payments or another type of risk-sharing arrangement to lower costs and provide better care
2. Surgeon benefits. Within the company's model, surgeons partner with PDP to lower supply chain costs and control physician preference item decisions. In return, they share in the savings generated by the model. Mr. Truhe says that since physicians take real risk, maintain independence from manufacturers, and operate under strict compliance requirements, this type of venture complies with current regulatory guidance from the Office of the Inspector General.
3. Device company benefits. PDP holds an event where device companies can display their products and invites participating surgeons to examine their options and then make decisions about which devices to use. This access to surgeons is highly sought after and shows that device companies are willing to partner with physicians in their cost-cutting initiatives going forward.
Orthopedic & Spine Industry Company to Know: PDP HoldingsWritten by Laura Dyrda | Thursday, 15 November 2012 16:39
One of the biggest expenses in orthopedic and spine surgery is device and implant costs. Providers often pay a premium for name-brand products, many of which are actually commodities, and the sales representatives that come along with them. However, downward pressure on reimbursement is forcing providers to examine healthcare costs and cut those costs wherever necessary to provide true value-based healthcare.
© Copyright ASC COMMUNICATIONS 2016. Interested in LINKING to or REPRINTING this content? View our policies here.
Most Read - Devices & Implants
- Is the Johnson & Johnson job cut an ominous sign for the medical device industry? 5 key thoughts
- DePuy Synthes, Medtronic, NuVasive & Stryker lead the US lateral lumbar interbody fusion market — 5 observations
- Johnson & Johnson to cut 6% of medical device jobs — 5 things to know
- SeaSpine, K2M, Smith & Nephew & more: 19 key notes
- Moody's: 3 important insights into the orthopedic device industry in 2016
Top 40 Articles from the Past 6 Months
- Cleveland Clinic standardizes to 2 implant vendors, at least one orthopedic surgeon out
- 22 minimally invasive spine devices to know
- 5 things to know about physician assistant pay
- Becker's Spine Review Channels
- Did this orthopedic surgeon let his PA perform surgery? Dr. Munir Uwaydah faces conspiracy, $150M fraud & aggravated mayhem charges: 6 key notes
- Surface technology for spine devices: Key trends & concepts
- Orthopedic surgeon Dr. Michael Reilly's whistleblower lawsuit results in $69M+ penalty for Broward Health — 7 things to know
- 15 things to know about physician shortages
- Current annual & hourly salary rates for orthopedic surgeons: 8 statistics
- 334 spine surgeons to know — 2016
- Dr. Richard Rooney pleads guilty to undisclosed financial interest, sentenced to prison: 5 things to know
- Dr. Sang-Ho Lee awarded Parviz Kambin award for endoscopic spine surgery at NASS meeting: 5 highlights
- Physician stabbed in Virginia leaving clinic — Attacker wanted more pain meds
- Rumors of a Stryker acquisition of Smith & Nephew swirl once again: 6 key notes
- Stryker recalls 16k+ units of orthopedic products: 5 takeaways
- The future of private practice: Key thoughts from OrthoCarolina CEO Dr. Daniel Murrey
- 5 trends putting the squeeze on surgical practices
- MIS, stem cells, biologics & more: What excites spine surgeons most about the current landscape?
- Transparency in healthcare can work today — Hoag Orthopedic Institute proves it
- Google and Johnson & Johnson to form new surgical company — 4 highlights
- Drs. Troy Caron, Raj Kakarlapudi, Jeff Martin join Laser Spine's surgery centers: 5 key points
- Global spine surgery device market seeing double-digit growth: 5 key points
- The theory behind Geisinger's spine surgery refund
- 8 surprising topics your spine patients are researching
- The ICD-10 deadline is almost upon us — Are spine surgeons ready?
- 5 key trends on Massachusetts physician pay — And what it means for US physicians
- 5 huge reputation management mistakes for surgeons
- Q2 financials: 150 things to know about NuVasive, Stryker, J&J Orthopedics & more
- 5 trends in the medical tourism market
- 10 statistics on neurosurgeon salaries & bonuses
- 10 key notes on the 2016 CMS physician fee schedule
- Stryker director sells 18k shares, following Smith & Nephew acquisition rumors: 7 points
- Intersecting care of spine pain specialists & spine surgeons: Drs. Heidi Prather & Scott Glaser talk pain
- Rothman Institute merges with OrthopaediCare; adds 17 physicians: 4 things to know
- Did Loma Linda's orthopedic device rep-less strategy work? 5 things to know
- Alphatec Spine, LDR, Globus Medical & more — 21 key notes
- Population health on a budget: How one orthopedic surgeon succeeded in Chicago's most impoverished neighborhoods
- Is PEEK cost-effective for spinal surgery? 5 things to know
- 32 hospitals to pay $28M in spine surgery false claims settlement: 5 things to know
- ProDisc-C vs. spinal fusion: Which has better results? 5 key notes